Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
25%
Ph phase_1
5
63%
Ph phase_4
1
13%

Phase Distribution

5

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
5(62.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(7)

Detailed Status

Completed7
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (62.5%)
Phase 41 (12.5%)
N/A2 (25.0%)

Trials by Status

completed788%
recruiting113%

Recent Activity

1 active trials
Showing 5 of 8
recruitingnot_applicable

A Trial of Three- and Seven-days Insulin Infusions Set

NCT06532461
completedphase_1

AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study

NCT05754424
completedphase_4

Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)

NCT03328845
completednot_applicable

Fast Advanced Closed-Loop Therapy

NCT04853030
completedphase_1

AT278 and NovoRapid® in Glucose Clamp Study

NCT04660305
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06532461Not Applicable

A Trial of Three- and Seven-days Insulin Infusions Set

Recruiting
NCT05754424Phase 1

AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study

Completed
NCT03328845Phase 4

Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)

Completed
NCT04853030Not Applicable

Fast Advanced Closed-Loop Therapy

Completed
NCT04660305Phase 1

AT278 and NovoRapid® in Glucose Clamp Study

Completed
NCT03981627Phase 1

A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

Completed
NCT03959514Phase 1

AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

Completed
NCT03179332Phase 1

A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8